Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc.
Insider Sentiment (TTM):
No insider data available
Institutional Sentiment:
As of:N/AInstitutional Shares Owned:N/AShares Outstanding:N/AInstitutional Ownership Pct.:N/A
Earnings Market Reaction:
Filing Date:2026-04-16Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Cannabis Bioscience International Holdings, Inc. (CBIH) — SEC Financial Statements & Analysis
Cannabis Bioscience International Holdings, Inc. (CBIH) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||
Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets Current | ||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables Net Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | |||||
Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | ||||||||||||||
Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Bank Overdrafts | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Deferred Revenue Current | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Deferred Revenue | - | - | 0 | - | - | - | - | - | - | |||||
Interest Payable Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | |||||
Liabilities Current | ||||||||||||||
Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Short Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Loans Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Loans Payable Current | - | - | - | - | - | - | - | 0 | - | |||||
Derivative Liabilities Current | 0 | 0 | 0 | 0 | 0 | - | 0 | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Convertible Notes Payable Current | 0 | 0 | 0 | 0 | - | - | 0 | - | - | |||||
Notes Payable | - | - | - | 0 | 0 | - | 0 | - | - | |||||
Liabilities Noncurrent | ||||||||||||||
Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Loans Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Stockholders Equity | ||||||||||||||
Additional Paid In Capital | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 | |||||
Stockholders Equity | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |||||
Retained Earnings Accumulated Deficit | -6 | -6 | -6 | -6 | -6 | -5 | -5 | -5 | -5 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Outstanding | - | - | - | 0 | 0 | 0 | 0 | - | - | |||||
Common Stock Shares Authorized | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | |||||
Common Stock Shares Issued | 11,627 | 11,627 | 11,627 | 11,627 | 10,932 | 10,557 | 10,432 | 10,432 | - | |||||
Shares Outstanding | 11,627 | 11,627 | 11,627 | 11,627 | 10,932 | 10,557 | 10,432 | 10,432 | 10,332 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.00% | 40.00% | 40.00% | 12.50% | 0.00% | -25.00% | -25.00% | 0.00% | -25.00% | - | - | - |
| 2025 | -7.14% | -14.29% | -14.29% | - | - | - | -14.29% | -14.29% | -14.29% | 8.70% | 8.70% | 52.17% |
| 2024 | - | - | - | 20.00% | 80.00% | 30.00% | 0.00% | -8.33% | 50.00% | -13.33% | -16.00% | -20.00% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 50+ calculated metrics
Subscribe to unlock 17+ years of data and 50+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | ||||||||||||||
| Current Ratio | 0.00 | 0.02 | 0.02 | 0.03 | 0.00 | 0.02 | 0.02 | 0.02 | 0.03 | |||||
| Quick Ratio | 0.00 | 0.02 | 0.02 | 0.03 | 0.00 | 0.02 | 0.02 | 0.02 | 0.03 | |||||
| Working Capital | -1.22M | -1.11M | -996.73K | -916.88K | -966.27K | -833.35K | -860.42K | -782.62K | -640.57K | |||||
Leverage & Debt | ||||||||||||||
| Debt to Equity | -1.00 | -1.02 | -1.02 | -1.03 | -1.01 | -1.04 | -1.05 | -1.10 | -1.12 | |||||
| Interest Coverage TTM | -2.91 | -2.92 | -3.23 | -2.71 | -3.45 | -3.13 | -7.67 | 15.35 | 119.05 | |||||
| Debt Ratio | 951.21 | 62.60 | 66.79 | 37.50 | 83.33 | 23.80 | 19.88 | 11.39 | 9.27 | |||||
Efficiency & Turnover | ||||||||||||||
| Asset Turnover TTM | 24.09 | 5.89 | 8.60 | 7.18 | 6.49 | 0.01 | 0.16 | 0.46 | 406.98 | |||||
| Days Sales Outstanding TTM | 3.60 | 35.29 | 16.23 | 9.46 | 10.62 | 9,756.03 | 983.27 | 328.17 | 0.17 | |||||
| Receivables Turnover TTM | 101.32 | 10.34 | 22.49 | 38.57 | 34.38 | 0.04 | 0.37 | 1.11 | 2,136.16 | |||||
Per Share Metrics | ||||||||||||||
| Diluted EPS TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | |||||
| Free Cash Flow Per Share TTM | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | ||||||||||||||
| Gross Profit Margin TTM | 82.80% | 75.01% | 85.25% | 86.98% | 84.62% | 87.38% | 22.93% | 28.43% | 31.50% | |||||
| Operating Profit Margin TTM | -231.69% | -245.25% | -151.62% | -144.57% | -163.22% | -136.48% | -17.08% | 6.45% | 15.40% | |||||
| Net Profit Margin TTM | -300.60% | -333.39% | -192.98% | -191.84% | -207.03% | -170.12% | -21.46% | 0.95% | 8.54% | |||||
Growth Metrics | ||||||||||||||
| Net Revenue Growth (1Y) | -47.78% | -52.87% | -96.29% | -98.13% | -99.09% | - | - | - | - | |||||
| Net Income Growth (1Y) | -24.18% | -7.63% | -66.64% | -475.75% | -122.16% | - | - | - | - | |||||
| EPS Growth (1Y) | -30.05% | -16.91% | -70.40% | -463.69% | -121.34% | - | - | - | - | |||||
Valuation Metrics | ||||||||||||||
| P/E TTM | -7.82 | -8.65 | -12.89 | -7.42 | -10.26 | -12.22 | -3.27 | 33.73 | 2.48 | |||||
| P/B | -3.17 | -4.26 | -6.53 | -5.53 | -6.56 | -8.42 | -5.74 | -7.97 | -10.43 | |||||
| P/S TTM | 23.50 | 28.84 | 24.87 | 14.23 | 21.23 | 20.78 | 0.70 | 0.32 | 0.21 | |||||
| Market Cap | 4.65M | 5.81M | 8.14M | 6.43M | 8.04M | 8.89M | 6.19M | 7.78M | 8.78M | |||||
| Enterprise Value | 4.67M | 5.83M | 8.16M | 6.44M | 8.08M | 8.90M | 6.20M | 7.79M | 8.79M | |||||
Calculated Values | ||||||||||||||
| Free Cash Flow TTM | -268.11K | -438.83K | -463.75K | -534.48K | -399.24K | -509.80K | -2.07M | -3.14M | -2.65M | |||||
| Net Debt | 14.50K | 14.56K | 20.73K | 10.82K | 34.96K | 6.09K | 6.30K | 6.26K | 11.74K | |||||
Per-Share and Margin | ||||||||||||||
| EPS TTM | ||||||||||||||
| Adjusted EPS TTM | ||||||||||||||
| Cash Flow Per Share TTM | ||||||||||||||
| Pretax Margin TTM | ||||||||||||||
| Stock Comp to Revenue TTM | ||||||||||||||
Turnover Ratios and Averages | ||||||||||||||
| Average Assets | ||||||||||||||
| Average Equity | ||||||||||||||
| Average Inventory | ||||||||||||||
| Average Receivables | ||||||||||||||
| Average Accounts Payables | ||||||||||||||
| Inventory Turnover TTM | ||||||||||||||
| Payables Turnover TTM | ||||||||||||||
| Days Inventory Outstanding TTM | ||||||||||||||
| Days Payables Outstanding TTM | ||||||||||||||
| Cash Conversion Cycle TTM | ||||||||||||||
| Working Capital to Revenue | ||||||||||||||
| Deferred Revenue to Revenue | ||||||||||||||
Growth Rates | ||||||||||||||
| Total Assets Growth (1Y) | ||||||||||||||
| Total Assets Growth (3Y) | ||||||||||||||
| Total Assets Growth (5Y) | ||||||||||||||
| Dividends Paid Growth (1Y) | ||||||||||||||
| Dividends Paid Growth (3Y) | ||||||||||||||
| Dividends Paid Growth (5Y) | ||||||||||||||
| EPS Growth (3Y) | ||||||||||||||
| EPS Growth (5Y) | ||||||||||||||
| Net Income Growth (3Y) | ||||||||||||||
| Net Income Growth (5Y) | ||||||||||||||
| Net Profit Margin Growth (1Y) | ||||||||||||||
| Net Profit Margin Growth (3Y) | ||||||||||||||
| Net Profit Margin Growth (5Y) | ||||||||||||||
| Net Revenue Growth (3Y) | ||||||||||||||
| Net Revenue Growth (5Y) | ||||||||||||||
| Deferred Revenue Growth (1Y) | ||||||||||||||
| Retained Earnings Growth (1Y) | ||||||||||||||
Credit, Liquidity, Returns, Payout | ||||||||||||||
| Cash Ratio | ||||||||||||||
| Net Working Capital | ||||||||||||||
| Debt to EBITDA TTM | ||||||||||||||
| Net Debt to EBITDA TTM | ||||||||||||||
| Net Debt to Equity | ||||||||||||||
| Altman A | ||||||||||||||
| Altman B | ||||||||||||||
| Altman C | ||||||||||||||
| Altman D | ||||||||||||||
| Altman E | ||||||||||||||
| Altman Z-Score | ||||||||||||||
| ROA TTM | ||||||||||||||
| ROE TTM | ||||||||||||||
| NOPAT TTM | ||||||||||||||
| ROIC TTM | ||||||||||||||
| Effective Tax Rate TTM | ||||||||||||||
| Payout Ratio TTM | ||||||||||||||
| Dilution Ratio | ||||||||||||||
| Retained Earnings to Equity | ||||||||||||||
| Treasury Stock to Equity | ||||||||||||||
| Treasury Stock Change (1Y) | ||||||||||||||
| Accrued to Current Liabilities | ||||||||||||||
Valuation Ratios | ||||||||||||||
| P/CF TTM | ||||||||||||||
| Dividend Yield TTM | ||||||||||||||
| Free Cash Flow Yield TTM | ||||||||||||||
| EV EBITDA TTM | ||||||||||||||
| EV EBIT TTM | ||||||||||||||
| Stock Compensation TTM | ||||||||||||||
| Adjusted Net Income TTM | ||||||||||||||
| Billings TTM | ||||||||||||||
| Total Debt | ||||||||||||||
| Invested Capital | ||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
No insider data available.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
No institutional ownership data available.